Azepane-4-carbonitrile, 95+%, 500mg

4-Hydroxy-4-o-tolylpiperidine-1-carboxylic acid tert-butyl ester, 98%, 1g

5-FLUORO-2-METHYL-3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)ANILINE, 95.0%, 100mg

Nonyl acetate, 98%, 100g

1-cyclopentyl-3-hydroxy-4,4-dimethylpent-2-en-1-one, 98%, 500mg

1-(3-Fluoro-4-methoxyphenyl)cyclopropanamine hydrochloride, 95.0%, 500mg

1-Ethynyl-1-cyclohexanol>98.0%(GC)25g

3-Chloroisonicotinic acid, 98.0%, 5g

N-benzyl-2-chloro-5,6,7,8-tetrahydroquinazolin-4-amine, 95%, 250mg

Cyclopropyl(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5,6-dihydropyridin-1(2H)-yl)methanone, 95.0%, 5g

Colonne HPLC NUCLEODUR® 300-5 C4 ec, 250 mm, 4 mm, 1 pièce(s)

(R)-1-(4-iodophenyl)ethan-1-amine, 250mg

2-Methylpyrazolo[1,5-a]pyridine-3-carboxylic acid, 95+%, 100mg